<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is one of the most commonly diagnosed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>A genome-wide screening of transcriptome dysregulation between <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissue would provide insight into the molecular basis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> initiation and progression </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with microarray technology, which is commonly used to identify transcriptional changes, the recently developed <z:chebi fb="40" ids="33697">RNA</z:chebi>-seq technique has the ability to detect other abnormal regulations in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> transcriptome, such as alternative splicing, novel transcripts or gene fusion </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we performed high-throughput transcriptome sequencing at ~50Ã— coverage on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, adjacent non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and distant <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="4" pm="."><plain>The results revealed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific, differentially expressed genes and differential alternative splicing, suggesting that the extracellular matrix and metabolic pathways are activated and the genes related to cell homeostasis are suppressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, one <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-restricted gene fusion, PRTEN-NOTCH2, was also detected and experimentally confirmed </plain></SENT>
<SENT sid="6" pm="."><plain>This study reveals some common features in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion and provides a comprehensive survey of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> transcriptome, which provides better insight into the complexity of regulatory changes during <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>